U.S. markets closed
  • S&P Futures

    4,010.75
    +3.50 (+0.09%)
     
  • Dow Futures

    32,665.00
    +34.00 (+0.10%)
     
  • Nasdaq Futures

    12,802.75
    +14.25 (+0.11%)
     
  • Russell 2000 Futures

    1,770.50
    +3.20 (+0.18%)
     
  • Crude Oil

    72.78
    -0.03 (-0.04%)
     
  • Gold

    1,962.00
    +8.20 (+0.42%)
     
  • Silver

    23.25
    +0.10 (+0.45%)
     
  • EUR/USD

    1.0817
    +0.0013 (+0.12%)
     
  • 10-Yr Bond

    3.5280
    +0.1480 (+4.38%)
     
  • Vix

    20.60
    -1.14 (-5.24%)
     
  • GBP/USD

    1.2314
    +0.0033 (+0.26%)
     
  • USD/JPY

    130.7230
    -0.8320 (-0.63%)
     
  • Bitcoin USD

    27,015.77
    -857.22 (-3.08%)
     
  • CMC Crypto 200

    589.59
    -17.86 (-2.94%)
     
  • FTSE 100

    7,471.77
    +66.32 (+0.90%)
     
  • Nikkei 225

    27,489.59
    +12.72 (+0.05%)
     

3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023

3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023

Individual investors who want help picking stocks have more than a few options to choose from, including the recommendations of Wall Street analysts. Right now, InMode (NASDAQ: INMD) is a medical technology stock that analysts on Wall Street can't seem to get enough of. Among those who follow InMode, the average analyst is targeting a 47% gain for the stock over the next year.